WHO recommends the continued use of AstraZeneca’s corona vaccine

AstraZeneca vaccinePhoto: Stian Lysberg Solum / NTB

The World Health Organization is still reviewing information on AstraZeneca’s vaccine and its possible link to blood clots. However, it recommends the continued use of the vaccine.

“Our Vaccine Safety Committee thoroughly assesses all available safety data. At present, the WHO believes that the benefits of AstraZeneca’s vaccine outweigh the risks and recommends that vaccination be continued,” a statement from the UN agency noted.

“Vaccination against COVID-19 does not reduce illness or death caused by other things. Blood clots are known to occur frequently. Blood clots in the veins are the third most common cardiovascular disease in the world,” the WHO noted.

The organization promised to publish the conclusions as soon as the Safety Committee has finished its work.

Use of vaccines put on hold

A number of countries, including Norway, have put the use of the vaccine on hold after several cases of blood clots have been registered in people who have received the vaccine.

On Tuesday, the European Medicines Agency (EMA) issued the same recommendation as the WHO and said that the benefit more than outweighs the risk associated with the vaccine. 

The EMA’s drug safety committee is expected to complete a separate review on Thursday.

Around 17 million people in the EU and the UK have received at least one dose of the vaccine. AstraZeneca has previously stated that they have received reports of 37 cases of blood clots among the vaccinated.

Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews

Do you have a news tip for Norway Today? We want to hear it. Get in touch at info@norwaytoday.no


Be the first to comment on "WHO recommends the continued use of AstraZeneca’s corona vaccine"

Leave a comment

Your email address will not be published.